Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | MGLL | Q99685 | 6/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8886446 | 0.87 | MGLL (0.45) | MGLLSMN1; SMN2 | |
| SCHEMBL10015231 | 0.87 | MGLL (0.49) | TDP1MGLLALDH1A1TP53CYP3A4 | |
| SCHEMBL10367241 | 0.86 | TDP1 (0.42) | TDP1MGLL | |
| SCHEMBL230593 | 0.82 | L3MBTL1 (0.41) | TDP1MGLL | |
| SCHEMBL13796548 | 0.81 | MGLL (0.45) | MGLL | |
| SCHEMBL4838795 | 0.81 | ALDH1A1 (0.51) | TDP1MGLLALDH1A1TP53CYP3A4 | |
| SCHEMBL10367463 | 0.81 | TMEM97 (0.47) | — | |
| SCHEMBL10015229 | 0.81 | MGLL (0.40) | TDP1MGLLSMN1; SMN2 | |
| SCHEMBL10366578 | 0.81 | MGLL (0.43) | TDP1MGLL | |
| SCHEMBL13771512 | 0.80 | ALDH1A1 (0.40) | MGLLALDH1A1TP53CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120029116-A1 | CURABLE ADHESIVE COMPOSITIONS, PROCESS, AND APPLICATIONS | TRILLION SCIENCE, INC. (US) | 2012-02-02 | — | — | US | disclosed |
| US-20120029116-A1 | CURABLE ADHESIVE COMPOSITIONS, PROCESS, AND APPLICATIONS | TRILLION SCIENCE, INC. (US) | 2012-02-02 | — | — | US | disclosed |
| US-20120029116-A1 | CURABLE ADHESIVE COMPOSITIONS, PROCESS, AND APPLICATIONS | TRILLION SCIENCE, INC. (US) | 2012-02-02 | — | — | US | disclosed |
| US-8084553-B2 | Curable adhesive compositions, process, and applications | TRILLION SCIENCE, INC. (US) | 2011-12-27 | — | — | US | disclosed |
| US-8084553-B2 | Curable adhesive compositions, process, and applications | TRILLION SCIENCE, INC. (US) | 2011-12-27 | — | — | US | disclosed |
| US-20090181165-A1 | Curable adhesive compositions, Process, and applications | TRILLION SCIENCE, INC. (US) | 2009-07-16 | — | — | US | disclosed |
| US-20090181165-A1 | Curable adhesive compositions, Process, and applications | TRILLION SCIENCE, INC. (US) | 2009-07-16 | — | — | US | disclosed |
| US-20090181165-A1 | Curable adhesive compositions, Process, and applications | TRILLION SCIENCE, INC. (US) | 2009-07-16 | — | — | US | disclosed |
| WO-2009089314-A1 | CURABLE ADHESIVE COMPOSITIONS, PROCESS, AND APPLICATIONS | TRILLION SCIENCE, INC. (US) | 2009-07-16 | — | — | WO | disclosed |
| WO-2009089314-A1 | CURABLE ADHESIVE COMPOSITIONS, PROCESS, AND APPLICATIONS | TRILLION SCIENCE, INC. (US) | 2009-07-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120029116-A1 | CURABLE ADHESIVE COMPOSITIONS, PROCESS, AND APPLICATIONS | RBX1, SUZ12, CDH1 | TDP1 620/4885MGLL 3210/4885ALDH1A1 429/4885 |
| US-20090181165-A1 | Curable adhesive compositions, Process, and applications | RBX1, SUZ12, CDH1 | TDP1 620/4885MGLL 3210/4885ALDH1A1 429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.